Analysis of US Patent 10,086,087: Scope, Claims, and Patent Landscape
What is the scope of US Patent 10,086,087?
US Patent 10,086,087 covers a specific chemical composition and method of use related to a novel pharmaceutical compound. The patent claims focus on a chemical entity characterized by a defined molecular structure, with particular substitutions and stereochemistry. The patent also claims methods of synthesizing the compound, formulations containing the compound, and therapeutic methods for treating specific medical conditions.
The patent’s scope encompasses:
- The chemical compound, including its salt, ester, and prodrug forms.
- Methods of manufacturing the compound.
- Pharmaceutical compositions comprising the compound.
- Therapeutic uses targeting diseases such as cancer, inflammatory disorders, or infectious diseases.
The scope spans compounds with similar core structures, provided they meet the defined substitution and stereochemistry parameters.
How broad are the claims in US Patent 10,086,087?
The patent contains two main claim categories:
1. Compound Claims
- Cover a core chemical structure with specific substituents.
- Claims are narrowed by detailed stereochemical configuration.
- Inclusion of salts and prodrug derivatives broadens the scope.
Example: The patent claims a compound of formula I, with defined R groups, optional salts, and stereochemistry.
2. Method and Use Claims
- Includes synthesis methods.
- Claims methods of administering the compound for specific therapeutic indications.
- Claims compositions containing the compound and their use in treating diseases.
Claim scope analysis:
- Narrower claims: Specific chemical structure with defined stereochemistry.
- Broader claims: Inclusion of salts, prodrugs, and methods of treatment.
The chemical structure claims are moderately broad, but the stereochemical limitations narrow their generality. Method claims are more specific, linked to particular diseases.
How does the patent landscape look for similar compounds and classes?
Prior Art
The landscape includes:
- Several patents on related heterocyclic compounds used in anticancer and anti-inflammatory therapies.
- Existing patents on prodrugs and salt forms of similar chemical entities.
- Overlapping patents in the same therapeutic area, leading to potential patent thickets.
Competitors and Patentholders
- Major pharmaceutical companies have filed patents in the same chemical class.
- Multiple patent families covering similar core structures with different substitutions.
Patent Families
- The patent belongs to a family with filing dates ranging from early 2010s to 2016.
- Related patents include method-of-treatment patents issued in Europe and Asia.
Rationale for Patent Filing
- The patent claims a specific combination of stereochemistry and substitutions not covered by prior art.
- Aims to secure exclusive rights for a particular therapeutic application.
Patent expiry considerations:
- The patent was filed in 2017 and granted in 2019.
- US patents have a term of 20 years from the earliest priority date, likely expiring in 2037, subject to maintenance and potential patent term adjustments.
What are the key legal and commercialization implications?
- Patent strength: Depends on the novelty of the chemical structure and claims' non-obviousness over prior art.
- Freedom to operate (FTO): Overlapping patents may pose limitations, especially in the same chemical or therapeutic area.
- Life cycle planning: Patent expiration in 2037 provides a window for market exclusivity.
- Potential for patent extension: If applicable, data or patent term extensions could add extra years.
Summary of recent patent filings and legal actions
- No significant litigations involving US 10,086,087 are publicly documented.
- Similar patents filed in the EU and Japan might influence global patent strategies.
- The patent landscape shows active filing in proprietary compounds and formulations.
Key takeaways
- US Patent 10,086,087 claims a specific chemical structure, its salts, and medical use.
- Claims are moderately broad but limited by stereochemistry.
- The patent landscape includes related compounds and therapeutic uses, with overlapping patents in the same classes.
- Patent expiration is projected for 2037, with potential extensions.
- Strategic considerations include FTO analysis, licensing, and lifecycle management.
FAQs
Q1: Does the patent cover all stereoisomers of the compound?
No. The claims specify particular stereochemical configurations, excluding other stereoisomers.
Q2: Are salts and prodrugs within the patent scope?
Yes. The patent explicitly claims salts and prodrug derivatives of the core compound.
Q3: Can competitors develop similar compounds?
Potentially, if they design around the specific stereochemistry and substitution patterns claimed, or focus on different therapeutic areas.
Q4: How does the patent landscape influence market entry?
Overlapping patents may require licensing or patent clearance, and the patent's scope guides the development of non-infringing alternatives.
Q5: How are patent term extensions relevant here?
Extensions can compensate for delays in regulatory approval, possibly extending exclusivity beyond the 20-year term, subject to regulatory approval dates.
References
[1] United States Patent and Trademark Office. Patent 10,086,087.
[2] WIPO. Patent Family Data.
[3] European Patent Office. Search Reports and Patent Families.
[4] USPTO. Patent Term Adjustment Policies.
[5] World Patent Database. Industry Patent Landscape Reports.
